Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study
Carolyn S.P. Lam, Greg Gamble, Lieng H. Ling, et al.
European Heart Journal (2018) Vol. 39, Iss. 20, pp. 1770-1780
Open Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
Biykem Bozkurt, Andrew J.S. Coats, Hiroyuki Tsutsui, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 3, pp. 352-380
Open Access | Times Cited: 1049
Universal Definition and Classification of Heart Failure
Biykem Bozkurt, Andrew J.S. Coats, Hiroyuki Tsutsui
Journal of Cardiac Failure (2021) Vol. 27, Iss. 4, pp. 387-413
Open Access | Times Cited: 620
Heart failure with mid-range or mildly reduced ejection fraction
Gianluigi Savarese, Davide Stolfo, Gianfranco Sinagra, et al.
Nature Reviews Cardiology (2021) Vol. 19, Iss. 2, pp. 100-116
Open Access | Times Cited: 300
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19
Jesús Álvarez‐García, Samuel Lee, Arjun Gupta, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 20, pp. 2334-2348
Open Access | Times Cited: 199
Cancer and heart disease: associations and relations
Rudolf A. de Boer, Wouter C. Meijers, Peter van der Meer, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 12, pp. 1515-1525
Open Access | Times Cited: 185
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study
Jasper Tromp, Sahiddah Bamadhaj, John G.F. Cleland, et al.
The Lancet Global Health (2020) Vol. 8, Iss. 3, pp. e411-e422
Open Access | Times Cited: 161
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
Julio A. Chirinos, Alena Orlenko, Lei Zhao, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 11, pp. 1281-1295
Open Access | Times Cited: 161
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure
Joyce Njoroge, John R. Teerlink
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1468-1486
Open Access | Times Cited: 135
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, et al.
Journal of Cardiac Failure (2021) Vol. 27, Iss. 12, pp. 1404-1444
Open Access | Times Cited: 115
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D. Anker, Muhammad Usman, Markus S. Anker, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 936-955
Open Access | Times Cited: 78
Heart failure with preserved ejection fraction
Carine E. Hamo, Colette DeJong, Nick Hartshorne‐Evans, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 37
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
Biykem Bozkurt, Tariq Ahmad, Kevin Alexander, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 30
Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial
Kristoffer Berg‐Hansen, Nigopan Gopalasingam, Kristian Hylleberg Christensen, et al.
Circulation (2024) Vol. 149, Iss. 19, pp. 1474-1489
Open Access | Times Cited: 29
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
Khibar Salah, Susan Stienen, Yigal M. Pinto, et al.
Heart (2019), pp. heartjnl-314173
Open Access | Times Cited: 132
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Circulation Heart Failure (2019) Vol. 12, Iss. 12
Open Access | Times Cited: 107
Pulmonary Hypertension in HFpEF and HFrEF
Marco Guazzi, Stefano Ghio, Yochai Adir
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 9, pp. 1102-1111
Open Access | Times Cited: 106
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
Giuseppe Vergaro, Nicolò Ghionzoli, Lisa Innocenti, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 20
Open Access | Times Cited: 86
Geriatric nutritional risk index predicts all‐cause deaths in heart failure with preserved ejection fraction
Isao Nishi, Yoshihiro Seo, Yoshie Hamada‐Harimura, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 2, pp. 396-405
Open Access | Times Cited: 85
Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes
Lee Lee Wong, Ruiyang Zou, Lihan Zhou, et al.
Journal of the American College of Cardiology (2019) Vol. 73, Iss. 11, pp. 1300-1313
Open Access | Times Cited: 81
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities
Zhiwei Li, Hongmei Zhao, Jing Wang
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 60
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, et al.
Circulation Journal (2021) Vol. 85, Iss. 12, pp. 2252-2291
Open Access | Times Cited: 60
Cardiac metabolism in HFpEF: from fuel to signalling
Federico Capone, Cristian Sotomayor-Flores, David Bode, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3556-3575
Open Access | Times Cited: 54
Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF
Erik Michaëlsson, Lars H. Lund, Camilla Hage, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 7, pp. 775-787
Open Access | Times Cited: 30
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
Gerasimos Filippatos, Stefan D. Anker, Phyllis August, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 2, pp. 183-191
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top